Drug profile · INN
radium ra223 dichloride
XOFIGO
radium ra223 dichloride (XOFIGO) is a radiotherapy agent.
EMA: approved Various (V10) V10XX03
Patents linked 0
Pipeline programs 6
News articles 0
Drug details — radium ra223 dichloride
- Class
- Various (V10)
- Route
- —
- Patents
- 0
- Programs
- 6
- Data quality
- 0.83
Quick answer
radium ra223 dichloride (XOFIGO) is a radiotherapy agent.
Key facts
INN radium ra223 dichloride
Brand XOFIGO
Mechanism Radiotherapy agent
Therapeutic class Various (V10)
ATC code V10XX03
Mechanism of action
Radiotherapy agent
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is radium ra223 dichloride?
radium ra223 dichloride (XOFIGO) is a radiotherapy agent.
What is the brand name for radium ra223 dichloride?
XOFIGO is a marketed brand name for radium ra223 dichloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.